AURKA and hepatocellular carcinoma: Interestingly, while AURKA appears to regulate MYCN's ability to bind Pol II promoters [21], the MYC-AURKA interaction enables hepatocellular carcinoma cells to overcome G2/M cell cycle arrest [18], suggesting reciprocal control.